查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614053

药物筛检市场：按产品类型、样本类型、最终用户划分 - 2025-2030 年全球预测

Drug Screening Market by Product (Consumables, Instruments, Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药物筛检市场价值为86.6亿美元，预计2024年将达到98.9亿美元，复合年增长率为14.42%，到2030年将达到222.5亿美元。

药物筛检市场是医疗保健和执法部门的重要组成部分，服务于广泛的应用，包括职场药物检测、医疗筛检、执法和运动兴奋剂检测。药物筛检的必要性源于药物滥用的增加以及药物成瘾对公共卫生和职场安全的重大影响。高灵敏度和快速检测方法的开发等技术开拓正在扩大应用范围并进一步推动市场成长。北美和欧洲等已开发地区对各领域的药物测试都有严格的规定，导致最终用途范围更广，也推动了需求。影响成长的关键因素包括人们对药物检测益处的认识提高、技术进步以及由于医疗保健基础设施改善而导致新兴市场药物检测量的增加。然而，隐私问题、误报的可能性以及先进测试方法的高成本等挑战可能会阻碍市场成长。儘管存在这些障碍，但创新的非侵入性测试技术和提供便利和高效的行动测试平台的开发正在出现新的商机。公司应重点研究和创新便携式、用户友好的检测套组以及与数位报告系统的集成，以满足对高效、即时测试结果日益增长的需求。此外，在药物滥用问题日益严重的发展中经济体中扩大服务提供了一条可行的成长道路。市场是动态的，竞争激烈，技术不断升级，需要不断适应。由于监管标准和需要大量资本投资而导致的进入障碍也可能是一项挑战。因此，公司应优先考虑提高监管专业知识和创新能力，以有效驾驭复杂的市场。

主要市场统计
基准年[2023] 86.6亿美元
预计年份 [2024] 98.9亿美元
预测年份 [2030] 222.5亿美元
复合年增长率（%） 14.42%

市场动态：揭示快速发展的药物筛检市场的关键市场洞察

供需的动态交互作用正在改变药物筛检市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球娱乐和处方药滥用激增
    • 提高职场安全性和合规性
    • 要求进行药物检测的政府法规和政策
  • 市场限制因素
    • 药物筛检结果被操纵的可能性
  • 市场机会
    • 创新药物筛检技术与套件的开发
    • 对行动和现场药物检测服务的需求不断增长
  • 市场挑战
    • 各国缺乏药物筛检的标准法规结构

波特五力：驾驭药物筛检市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物筛检市场的外部影响

外部宏观环境因素在塑造药物筛检市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药物筛检市场的竞争状况

药物筛检市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵药物筛检市场供应商绩效评估

FPNV定位矩阵是评估药物筛检市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药物筛检市场的成功之路

药物筛检市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球娱乐和处方药物滥用激增
      • 提高职场安全性和合规性
      • 要求进行药物测试的政府法规或组织政策
    • 抑制因素
      • 操纵药物筛检结果的可能性
    • 机会
      • 创新药物筛检技术与套件的开发
      • 对移动和现场药物检测服务的需求增加
    • 任务
      • 缺乏针对整个经济范围的药物筛检的标准法规结构
  • 市场区隔分析
    • 产品：非侵入性且可快速提供结果的口腔液检测设备的使用正在迅速增加
    • 最终使用者：药物筛检在戒毒治疗中心的重要用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药物筛检市场：副产品

  • 消耗品
    • 检测试剂套件
    • 校准器和控制装置
    • 样本采集管
  • 装置
    • 分析设备
      • 酒精检测仪
      • 燃料电池酒精检测仪
      • 半导体酒精检测仪
      • 层析法设备
      • 免疫检测分析仪
    • 快速检测装置
      • 口腔液检测装置
      • 尿液检查装置
      • 浸卡
      • 药物测试盒
      • 药物测试杯
  • 服务

第七章依样本类型分類的药物筛检市场

  • 呼吸样本
  • 头髮样本
  • 口腔液样本
  • 尿液样本

第八章药物筛检市场：依最终用户分类

  • 刑事司法系统与执法
  • 药物检测实验室
  • 戒毒治疗中心
  • 医院
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 职场

第九章美洲药物筛检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药物筛检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的药物筛检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 创新伙伴关係推出虚拟药物筛检平台
    • 精准背景推出先进药物及健康筛检服务
    • bioXcelerate 利用人工智慧驱动的筛检工具彻底改变药物发现
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AccuSourceHR, Inc.
  • ACM Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Danaher Corporation
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Intoximeters, Inc.
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies, Inc.
  • Merck KGaA
  • Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
  • OraSure Technologies, Inc.
  • Pfizer Inc.
  • Premier Biotech, LLC
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Sartorius AG
  • Securetec Detektions-Systeme AG
  • Shimadzu Corporation
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • United States Drug Testing Laboratories, Inc.
Product Code: MRR-DD6333AE5B92

The Drug Screening Market was valued at USD 8.66 billion in 2023, expected to reach USD 9.89 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 22.25 billion by 2030.

The drug screening market is a crucial component of the healthcare and law enforcement sectors, serving a wide range of applications such as workplace drug testing, medical screening, law enforcement, and sports doping tests. The necessity of drug screening arises from the increasing incidence of substance abuse and the significant impact of drug addiction on public health and workplace safety. Advances in technology, such as the development of highly sensitive and rapid testing methods, have expanded the application scope, further driving market growth. The demand is bolstered by stringent regulations in developed regions like North America and Europe, which mandate drug testing for various sectors, thus broadening the end-use scope. Key influencing growth factors include rising awareness about drug testing benefits, technological advancements, and the increasing volume of drug testing in emerging markets due to improved healthcare infrastructure. However, challenges such as privacy concerns, potential false positives, and the high cost of advanced testing methods can impede market growth. Despite these hurdles, emerging opportunities stem from the development of innovative non-invasive testing technologies and mobile testing platforms, which offer convenience and efficiency. Businesses should focus on research and innovation in portable and user-friendly testing kits, as well as integration with digital reporting systems, to capitalize on the increased demand for efficient and immediate results. Additionally, expanding services in growing economies with rising issues of drug abuse presents a viable growth path. The market is dynamic, characterized by aggressive competition and continuous technological upgrades, necessitating constant adaptation. Entry barriers due to regulatory standards and the need for significant capital investment can also pose challenges. Therefore, companies should prioritize building strong regulatory expertise and innovation capabilities to navigate market complexities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 22.25 billion
CAGR (%) 14.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Screening Market

The Drug Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in both recreational and prescription drug misuse globally
    • Increased safety and compliance in workplaces
    • Regulations by governments and organizational policies mandating drug testing
  • Market Restraints
    • Possibility of manipulation of drug screening results
  • Market Opportunities
    • Development of innovative drug screening technologies and kits
    • Growing demand for mobile and on-site drug testing services
  • Market Challenges
    • Lack of standard regulatory framework for drug screening across economies

Porter's Five Forces: A Strategic Tool for Navigating the Drug Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Screening Market

A detailed market share analysis in the Drug Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Screening Market

A strategic analysis of the Drug Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Merck KGaA, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Pfizer Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Sartorius AG, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Calibrators & Controls, and Sample Collection Tubes. The Instruments is further studied across Analytical Instruments and Rapid Testing Devices. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Breathalyzers is further studied across Fuel-Cell Breathalyzers and Semiconductor Breathalyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices. The Urine Testing Devices is further studied across Dip Cards, Drug Testing Cassettes, and Drug Testing Cups.
  • Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
  • Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Schools & Colleges, and Workplaces.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in both recreational and prescription drug misuse globally
      • 5.1.1.2. Increased safety and compliance in workplaces
      • 5.1.1.3. Regulations by governments and organizational policies mandating drug testing
    • 5.1.2. Restraints
      • 5.1.2.1. Possibility of manipulation of drug screening results
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of innovative drug screening technologies and kits
      • 5.1.3.2. Growing demand for mobile and on-site drug testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standard regulatory framework for drug screening across economies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
    • 5.2.2. End User: Significant utilization of the drug screening in the drug treatment centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Calibrators & Controls
    • 6.2.3. Sample Collection Tubes
  • 6.3. Instruments
    • 6.3.1. Analytical Instruments
      • 6.3.1.1. Breathalyzers
      • 6.3.1.1.1. Fuel-Cell Breathalyzers
      • 6.3.1.1.2. Semiconductor Breathalyzers
      • 6.3.1.2. Chromatography Instruments
      • 6.3.1.3. Immunoassay Analyzers
    • 6.3.2. Rapid Testing Devices
      • 6.3.2.1. Oral Fluid Testing Devices
      • 6.3.2.2. Urine Testing Devices
      • 6.3.2.2.1. Dip Cards
      • 6.3.2.2.2. Drug Testing Cassettes
      • 6.3.2.2.3. Drug Testing Cups
  • 6.4. Services

7. Drug Screening Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Screening Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Schools & Colleges
  • 8.9. Workplaces

9. Americas Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Innovative Partnership Launches Virtual Drug Screening Platform
    • 12.3.2. Launch of Accurate Background's Advanced Drug and Health Screening Services
    • 12.3.3. bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuSourceHR, Inc.
  • 3. ACM Global Laboratories
  • 4. Alfa Scientific Designs, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Clinical Reference Laboratory, Inc.
  • 7. Cordant Health Solutions
  • 8. Danaher Corporation
  • 9. Dragerwerk AG & Co. KGaA
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Intoximeters, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Lifeloc Technologies, Inc.
  • 14. Merck KGaA
  • 15. Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
  • 16. OraSure Technologies, Inc.
  • 17. Pfizer Inc.
  • 18. Premier Biotech, LLC
  • 19. Psychemedics Corporation
  • 20. Quest Diagnostics Incorporated
  • 21. Sartorius AG
  • 22. Securetec Detektions-Systeme AG
  • 23. Shimadzu Corporation
  • 24. Siemens AG
  • 25. Thermo Fisher Scientific Inc.
  • 26. United States Drug Testing Laboratories, Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 354. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA DRUG SCREENING MARKET SI